G2G CONSULTING

Lobbying for MAYNE PHARMA · Increasing access to pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Contraception coverage policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem